Clinical features of macrophage activation syndrome in the adult northern Chinese population

Lupus

Volumn 23, Issue 8, 2014, Pages 785-792

  Li, X ^a   Qu, B ^a   Nie, Y ^a   Zhu, G ^a   Li, W ^a   Mu, F ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Adult; MAS; Rheumatic disease

Indexed keywords

CREATININE; IMMUNOGLOBULIN; LIVER ENZYME; METHYLPREDNISOLONE; PREDNISONE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ADULT ONSET STILL DISEASE; ANEMIA; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; BONE MARROW HEMOPHAGOCYTOSIS; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CYTOPENIA; EPISTAXIS; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; HYPOFIBRINOGENEMIA; INTERSTITIAL PNEUMONIA; JAUNDICE; LENGTH OF STAY; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHADENOPATHY; MACROPHAGE ACTIVATION SYNDROME; MALE; MIDDLE AGED; MONOCYTE; PLASMAPHERESIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; TIME TO TREATMENT; UREA NITROGEN BLOOD LEVEL; YOUNG ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; RHEUMATIC DISEASE;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MACROPHAGE ACTIVATION SYNDROME; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; YOUNG ADULT;

EID: 84903545160     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314529467     Document Type: Article

References (27)

1. Stéphan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM. Macrophage activation syndrome and rheumatic disease in childhood: A report of four new cases. Clin Exp Rheumatol 1993; 11: 451-456.
2. Athreya BH. Is macrophage activation syndrome a new entity? Clin Exp Rheumatol 2002; 20: 121-123.
3. Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: The same entities? Curr Opin Rheumatol 2003; 15: 587-590.
4. Ramanan AV, Schneider R. Macrophage activation syndrome - what's in a name! J Rheumatol 2003; 30: 2513-2516.
5. Silverman ED, Miller JJ 3rd, Bernstein B, Shafai T. Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis. J Pediatr 1983; 103: 872-876.
6. De Vere-Tyndall A, Macauley D, Ansell BM. Disseminated intravascular coagulation complicating systemic juvenile chronic arthritis (''Still's disease''). Clin Rheumatol 1983; 2: 415-418.
7. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: Possible relationship to drugs or infection. J Pediatr 1985; 106: 561-566.
8. Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996; 128: 275-278.
9. Grom AA, Passo M. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr 1996; 129: 630-632.
10. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85: 421-426.
11. Stéphan JL, Koné-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001; 40: 1285-1292.
12. Ravelli A, Magni-Manzoni S, Pistorio A, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598-604.
13. Ziaee V, Moradinejad MH. Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders. Pediatr Rheumatol Online J 2008; 6(Suppl 1): P62.
14. Vilaiyuk S, Sirachainan N, Wanitkun S, Pirojsakul K, Vaewpanich J. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: A case-based review. Clin Rheumatol 2013; 32: 899-904.
15. Shimizu M, Yokoyama T, Tokuhisa Y, et al. Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome. Clin Immunol 2013; 146: 73-76.
16. Sawhney S, Woo P,Murray KJ. Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85: 421-426.
17. Bleesing J, Prada A, Siegel DM, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 965-971.
18. Ohlsson V, Baildam E, Foster H, et al. Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA). Rheumatology (Oxford) 2008; 47: 555-556.
19. Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996; 128: 275-278.
20. Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 2004; 104: 735-743.
21. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002; 14: 548-552.
22. Henter JI, Elinder G, Söder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918-2922.
23. Henter JI. Biology and treatment of familial hemophagocytic lymphohistiocytosis: Importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis. Med Pediatr Oncol 2002; 38: 305-309.
24. Henter JI, Samuelsson-Horne A, Arico M, et al Histocyte Society. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.
25. Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ. Successful treatment of severe paediatric rheumatic diseaseassociated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: Case series with 12 patients. Rheumatology (Oxford) 2011; 50: 417-419.
26. Bruck N, Suttorp M, Kabus M, Heubner G, Gahr M, Pessler F. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol 2011; 17: 23-27.
27. Sellmer A, Stausbøl-Grøn B, Krag-Olsen B, Herlin T. Successful use of infliximab in macrophage activation syndrome with severe CNS involvement. Scand J Rheumatol 2011; 40: 156-157.